N

NUCLEAR TECHNOLOGY AND CONSULTING (Public limited company)

BE 0430.093.050 Active ●Steenberg 43, 9401 Ninove

NUCLEAR TECHNOLOGY AND CONSULTING is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0430.093.050. It was founded on 22-12-1986. Its registered office is in Ninove. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 2 013 431 and a profit of € 10 933. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0430.093.050
VAT registered
No
Founded
22-12-1986
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Not registered
Registered office
Steenberg 43, 9401 Ninove
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
2110001 Etude, mise au point de la production des principes actifs destinés à la fabrication de médicaments

Key figures of NUCLEAR TECHNOLOGY AND CONSULTING

202520242023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 10 933-84 %€ 66 360€ -1 307
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 2 013 431+1 %€ 2 002 4990 %€ 1 996 711
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 2 058 117-2 %€ 2 092 7760 %€ 2 089 811
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -12 755+7 %€ -13 762-3 %€ -13 314
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
---

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
2 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity nearby.

CompanyTown
AJINOMOTO OMNICHEM 9230 Wetteren
I.D.A.S.I. 9140 Temse
-HEEL BELGIUM 9031 Gent
DELAVAL 9031 Gent
Conforma 9070 Destelbergen
Laboratoria Bota 9800 Deinze
Buckman Laboratories 9000 Gent
Etablissements Horticoles de Wanze 9140 Temse
Looking for more information about NUCLEAR TECHNOLOGY AND CONSULTING?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is NUCLEAR TECHNOLOGY AND CONSULTING still active? Yes. The Crossroads Bank for Enterprises lists NUCLEAR TECHNOLOGY AND CONSULTING as active.

What is the VAT number of NUCLEAR TECHNOLOGY AND CONSULTING? NUCLEAR TECHNOLOGY AND CONSULTING is not registered for VAT. Its enterprise number is 0430.093.050.

When was NUCLEAR TECHNOLOGY AND CONSULTING founded? NUCLEAR TECHNOLOGY AND CONSULTING was founded on 22-12-1986.

What is the address of NUCLEAR TECHNOLOGY AND CONSULTING? The current registered office of NUCLEAR TECHNOLOGY AND CONSULTING is Steenberg 43, 9401 Ninove.

When did NUCLEAR TECHNOLOGY AND CONSULTING last file annual accounts? The latest annual accounts of NUCLEAR TECHNOLOGY AND CONSULTING were filed on 20-03-2026.

Does NUCLEAR TECHNOLOGY AND CONSULTING file its annual accounts on time? Yes. NUCLEAR TECHNOLOGY AND CONSULTING filed its annual accounts within the legal deadline for each of its last 4 financial years.

Is NUCLEAR TECHNOLOGY AND CONSULTING financially healthy? Addrly gives NUCLEAR TECHNOLOGY AND CONSULTING a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is NUCLEAR TECHNOLOGY AND CONSULTING profitable? The annual accounts of NUCLEAR TECHNOLOGY AND CONSULTING for 2025 show a profit of € 10 933.

What is the equity of NUCLEAR TECHNOLOGY AND CONSULTING? The equity of NUCLEAR TECHNOLOGY AND CONSULTING was € 2 013 431 at the close of the 2025 financial year.

Who are the directors of NUCLEAR TECHNOLOGY AND CONSULTING? The annual accounts of NUCLEAR TECHNOLOGY AND CONSULTING record 2 mandates. The names, roles and dates are visible with a free account.

Can NUCLEAR TECHNOLOGY AND CONSULTING receive Peppol e-invoices? NUCLEAR TECHNOLOGY AND CONSULTING is not registered on the Peppol network at the moment.

What does NUCLEAR TECHNOLOGY AND CONSULTING do? The main activity of NUCLEAR TECHNOLOGY AND CONSULTING is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data